Esophageal cancer claims more American lives each year than melanoma and cervical cancer combined. Yet it receives only a fraction of the public awareness. Too often, it's diagnosed only after symptoms appear, when treatment options are more limited. The goal isn't to detect cancer—it's to find precancer first. Barrett's esophagus—the precancerous condition that can lead to esophageal adenocarcinoma—can be detected, monitored, and treated before cancer develops. EsoGuard® helps make that possible with a non-invasive test for at-risk patients. Awareness is the first step. Early detection is what changes outcomes.